EP3402486
CCX168 FOR USE IN THE TREATMENT OF C3 GLOMERULOPATHY
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
12.1.2017EP published:
19.3.2025EP application number:
17738902.0
EPO information:
European Patent Register
Max expiry date:
11.1.2037
Title in English:
CCX168 FOR USE IN THE TREATMENT OF C3 GLOMERULOPATHYLanguage of the patent:
English
Timeline
Today
12.1.2017EP application
19.3.2025EP Publication
Owner
Name:
ChemoCentryx, Inc.Address:
850 Maude Avenue, Mountain View, California 94043, US
Inventor
Name:
BEKKER, PetrusAddress:
Los Altos CA 94022, US
Priority
Number:
201662278788 PDate:
14.1.2016Country:
US
Number:
201662280346 PDate:
19.1.2016Country:
US
Number:
201662347450 PDate:
8.6.2016Country:
US
Number:
201662397527 PDate:
21.9.2016Country:
US
Classification
Categories:
A61K 31/551, A61P 13/12, A61K 31/454